PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
10-May-2023 Impact Shine Communications rolls in to advance Life Science Business and Marketing Strategies Impact Shine Communications Ltd
05-May-2023 Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award Tower Cold Chain
30-Mar-2023 Modus Therapeutics secures access to bridge financing from longstanding investor Karolinska Development Modus Therapeutics
30-Mar-2023 Tower Cold Chain secures spot in Financial Times top 1000 fastest-growing companies Tower Cold Chain
23-Mar-2023 InnoScot Health webinar set to share important insights on funding acceleration for innovators InnoScot Health
21-Mar-2023 Sustainability takes centre stage for Tower Cold Chain at LogiPharma Tower Cold Chain
07-Mar-2023 Wave signals intent with new senior hire Wave Healthcare Communications
22-Feb-2023 Pharma Targeting Celebrates 10 years of Connecting People Intelligently Pharma Targeting
21-Feb-2023 Consilium Strategic Communications expands international presence in US and Europe with two Senior Strategic Advisor appointments Consilium Strategic Communications
21-Feb-2023 Four-day work week (4DWW) experts Synergy Vision demonstrate four years of success, showing longevity beyond today’s UK Pilot Programme results Synergy Vision
20-Feb-2023 2San and LloydsPharmacy Partner to Bring Affordable and Accessible Diagnostic Tests To Market 2San
26-Jan-2023 Cherwell publishes new guide to EM best practice in compliance with revised Annex 1 Cherwell Laboratories
26-Jan-2023 Orbsen Therapeutics announces encouraging interim results from the NEPHSTROM proof of concept clinical study evaluating ORBCEL™ cell therapy in patients with diabetes and advanced chronic kidney disease Orbsen Therapeutics Limited
26-Jan-2023 First CAR T-cell therapy recommended for routine use on the NHS in England Gilead Sciences Ltd
26-Jan-2023 Bloomsbury Genetic Therapies Announces Orphan Drug Designations of BGT-DTDS for the Treatment of Dopamine Transporter Deficiency Syndrome Bloomsbury Genetic Therapies Limited
26-Jan-2023 Nutricia pioneers its first plant-based medical nutrition drink Nutricia
16-Jan-2023 The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations Merck
13-Jan-2023 Tower expands pharmaceutical corridors with new Singapore site Tower Cold Chain
12-Jan-2023 Novotech Acquires European CRO – Strengthens Global Operations Novotech
10-Jan-2023 More doctors joining the NHS as nearly 900 more specialty training posts announced by HEE Health Education England